Veloxis Pharmaceuticals Envarsus(R) Granted Orphan Drug Status by US Food ... Wall Street Journal The designation is to encourage the development of drugs that may provide significant benefit to patients suffering from rare diseases. Envarsus(R) is Veloxis' once-daily formulation of tacrolimus employing the company's proprietary MeltDose(R) technology. |
